XML 66 R36.htm IDEA: XBRL DOCUMENT v3.2.0.727
Share-Based Compensation (Tables)
12 Months Ended
Jun. 30, 2015
Share-based Compensation [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
Total share-based compensation included as a component of selling, general, and administrative expenses in our Consolidated Income Statements was as follows:

 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
 
(in thousands)
Share-based compensation related to:
 
 
 
 
 
Equity classified stock options
$
1,480

 
$
1,577

 
$
2,125

Equity classified restricted stock
5,042

 
3,671

 
3,493

Total share-based compensation
$
6,522

 
$
5,248

 
$
5,618

Weighted Average Assumptions for the Options Granted During the Following Fiscal Years
The Company used the following weighted-average assumptions for the options granted during the following fiscal years:

 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Expected term
4.02 years

 
4.00 years

 
4.64 years

Expected volatility
30.06
%
 
33.70
%
 
42.90
%
Risk-free interest rate
1.22
%
 
1.07
%
 
0.64
%
Dividend yield
0.00
%
 
0.00
%
 
0.00
%
Weighted-average fair value per option
$
10.51

 
$
11.91

 
$
10.48

Stock Option Plans
A summary of our stock option plans is presented below:

 
Fiscal Year Ended June 30, 2015
 
Options
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Life
 
Aggregate
Intrinsic
Value
Outstanding, beginning of year
1,071,097

 
$
33.91

 
 
 
 
Granted during the period
166,593

 
41.11

 
 
 
 
Exercised during the period
(71,659
)
 
31.43

 
 
 
 
Canceled, forfeited, or expired during the period

 

 
 
 
 
Outstanding, end of year
1,166,031

 
35.09

 
5.38
 
$
4,531,055

Vested and expected to vest at June 30, 2015
1,164,033

 
35.08

 
5.38
 
$
4,530,942

Exercisable, end of year
879,451

 
$
33.49

 
4.24
 
$
4,204,989

Unvested Shares
A summary of the status of the Company’s shares subject to unvested options is presented below:
 
Fiscal Year Ended June 30, 2015
 
Options
 
     Weighted     
Average
Exercise
Price
 
Weighted
Average
Grant
    Date Fair-    
Value
Unvested, beginning of year
250,932

 
$
36.93

 
$
11.72

Granted
166,593

 
41.11

 
10.51

Vested
(130,945
)
 
35.58

 
11.96

Canceled or forfeited

 

 

Unvested, end of year
286,580

 
$
39.98

 
$
10.91

Stock Options Outstanding
The following table summarizes information about stock options outstanding and exercisable as of June 30, 2015:

 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Shares
  Outstanding   
 
Weighted
Average
Remaining
  Contractual  
Life
 
    Weighted    
Average
Exercise
Price
 
Number
  Exercisable   
 
    Weighted    
Average
Exercise
Price
$18.13 - $22.27
 
8,400

 
3.43
 
$
18.14

 
8,400

 
$
18.14

$22.27 - $26.38
 
30,000

 
4.43
 
24.57

 
30,000

 
24.57

$26.38 - $30.49
 
217,558

 
4.00
 
28.94

 
178,656

 
28.77

$30.49 - $34.60
 
299,129

 
4.36
 
33.22

 
299,129

 
33.22

$34.60 - $38.71
 
323,995

 
4.17
 
36.43

 
322,345

 
36.43

$38.71 - $42.82
 
286,949

 
9.02
 
41.77

 
40,921

 
42.69

 
 
1,166,031

 
5.38
 
$
35.09

 
879,451

 
$
33.49

Restricted Stock Outstanding

A summary of the status of the Company’s outstanding restricted stock is presented below:

 
Fiscal Year Ended June 30, 2015
 
Shares
 
Weighted-Average
Grant Date Fair
Value
Outstanding, beginning of year
220,108

 
$
37.36

Granted during the period
194,232

 
40.87

Vested during the period
(119,995
)
 
36.90

Cancelled, forfeited, or expired during the period
(15,149
)
 
32.98

Outstanding, end of year
279,196

 
$
38.87

During the fiscal year ended June 30, 2015, the Company elected to grant 194,232 shares of restricted stock to employees and non-employee directors, all of which were issued in the form of RSUs or PUs:

 
Fiscal Year Ended June 30, 2015
 
Shares
granted
 
Date granted
 
Grant date
fair value
 
Vesting period
Employees
 
 
 
 
 
 
 
Certain employees, vesting based on certain service and performance conditions (1)
14,042
 
June 25, 2014
 
$
39.01

 
July 1, 2014 through June 30, 2017
Certain employees
2,006
 
August 26, 2014
 
38.83

 
Immediate vesting
Certain employees, vesting based on certain service and performance conditions
8,336
 
November 6, 2014
 
38.94

 
November 6, 2014 through July 1, 2016
Certain employees
150,143

 
December 5, 2014
 
41.13

 
Annually over 3 years
Certain employees
991

 
February 3, 2015
 
35.16

 
Annually over 3 years
Certain employees based on promotions
2,550
 
May 5, 2015
 
39.05

 
Annually over 3 years
Certain employees
1,664
 
June 5, 2015
 
39.21

 
Annually over 3 years
Non-Employee Directors(2)
 
 
 
 
 
 
 
Certain Directors
14,500
 
December 5, 2014
 
$
41.13

 
6 months
(1)
These RSU grants have service-based and performance-based vesting conditions. The total target shares under these grants are 14,042, but the actual number of shares that will vest depends on the performance of the Company. The grant date fair value of $39.01 is for the first tranche of these awards. The fair values for the second and third tranches of these awards has not yet been determined. See the The Company's 2014 Proxy Statement for further information about these grants.
(2)
Under the 2013 Long-Term Incentive Plan, non-employee directors will receive annual awards of restricted stock, as opposed to stock options. The number of shares of restricted stock to be granted will be established from time to time by the Board of Directors. Currently, the number of shares of restricted stock awarded annually to each non-employee director generally will be determined by dividing $100,000 by the equity award value of the common stock on the date of grant, as defined in the 2013 Long-Term Incentive Plan. The equity award value means the value per share based on a 45-day averaging of the fair market value of the common stock over a specified period of time, or the fair market value of the common stock on a specified date. These awards will generally vest in full on the day that is six months after the date of grant or upon the earlier occurrence of (i) the director’s termination of service as a director by reason of death, disability or retirement, or (ii) a change in control by the Company. The compensation expense associated with these awards will be recognized on a pro-rata basis over this period.